CurrentCardio
Get Weekly

Topic · page 15 of 21

Prevention & lipids

Lipids, Lp(a), lifestyle (activity, diet, alcohol, smoking), risk scores, primary prevention in general or older populations, frailty and CV risk

Briefs 561–600 of 838 placed here, newest publication first

Briefs in Prevention & lipids

Newest publication first

  1. J Am Coll Cardiol

    Higher Aircraft Noise Exposure Is Linked to Worse Heart Structure and Function by Cardiovascular MRI

    Cross-sectional study

  2. Eur Heart J

    Coffee drinking timing and mortality in US adults

    Cohort study

  3. JAMA

    Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores

    Cross-sectional study

  4. JAMA

    Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic Trial

    Randomised controlled trial

  5. JAMA

    Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)): A Phase 2 Randomized Clinical Trial

    Randomised controlled trial

  6. Eur J Prev Cardiol

    Traditional risk factors, optimal cardiovascular health, and elevated lipoprotein(a)

    Cohort study

  7. BMJ

    Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial

    Cohort study

  8. Eur J Prev Cardiol

    Association of modifiable lifestyle risk factors with high-sensitivity troponin T and I concentrations and clinical outcomes

    Cohort study

  9. Eur J Prev Cardiol

    Temporal trend and attributable risk factors of cardiovascular disease burden for adults 55 years and older in 204 countries/territories from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021

    Secondary analysis

  10. Eur J Prev Cardiol

    Nonobese young females with polycystic ovary syndrome are at high risk for long-term cardiovascular disease

    Cohort study

  11. JACC CardioOncol

    Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy

    Cross-sectional study

  12. J Am Coll Cardiol

    Accelerometer-Measured Sedentary Behavior and Risk of Future Cardiovascular Disease

    Cohort study

  13. Eur J Prev Cardiol

    Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia

    Secondary analysis

  14. J Am Coll Cardiol

    Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial

    Randomised controlled trial

  15. Circulation

    Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis

    Meta-analysis

  16. Eur J Prev Cardiol

    Impact of genetic risk information for cardiovascular disease on behavioural changes, psychological responses and risk factor modification: a systematic review

    Meta-analysis

  17. JAMA Cardiol

    Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors: The SAHELI Randomized Clinical Trial

    Randomised controlled trial

  18. JAMA Cardiol

    Tailoring Risk Prediction Models to Local Populations

    Cohort study

  19. Eur J Prev Cardiol

    Adding traditional and emerging biomarkers for risk assessment in secondary prevention: a prospective cohort study of 20 656 patients with cardiovascular disease

    Cohort study

  20. Eur J Prev Cardiol

    Intra-individual variability in lipoprotein(a) levels: findings from a large academic health system population

    Cohort study

  21. J Am Coll Cardiol

    The Effect of Teleprehabilitation on Adverse Events After Elective Cardiac Surgery: A Randomized Controlled Trial

    Randomised controlled trial

  22. Circulation

    Associations of Circulating ANGPTL3, C-Terminal Domain–Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality

    Cohort study

  23. J Am Coll Cardiol

    Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial

    Randomised controlled trial

  24. Eur J Prev Cardiol

    Can incidental physical activity offset the deleterious associations of sedentary behaviour with major adverse cardiovascular events?

    Cohort study

  25. Circulation

    Associations of “Weekend Warrior” Physical Activity With Incident Disease and Cardiometabolic Health

    Cohort study

  26. Eur J Prev Cardiol

    Heart rate response and recovery in cycle exercise testing: normal values and association with mortality

    Cohort study

  27. Circulation

    Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation

    Guideline or statement

  28. J Am Coll Cardiol

    Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review

    Research article

  29. Eur J Prev Cardiol

    Female participation, and sex-specific reporting practices, in polypill randomized controlled trials in the prevention of atherosclerotic cardiovascular disease: a secondary analysis of a systematic review

    Meta-analysis

  30. Circulation

    Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association

    Guideline or statement

  31. Eur J Prev Cardiol

    Intensity or volume: the role of physical activity in longevity

    Cohort study

  32. Eur J Prev Cardiol

    Global burden of cardiovascular diseases: projections from 2025 to 2050

    Secondary analysis

  33. J Am Coll Cardiol

    Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood

    Cohort study

  34. JACC Cardiovasc Imaging

    Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis

    Meta-analysis

  35. Eur Heart J

    Endometriosis and long-term cardiovascular risk: a nationwide Danish study

    Cohort study

  36. JAMA Cardiol

    Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial

    Secondary analysis

  37. JAMA Cardiol

    Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease: A Randomized Clinical Trial

    Randomised controlled trial

  38. Nat Med

    Unidirectional association of clonal hematopoiesis with atherosclerosis development

    Cohort study

  39. Eur J Prev Cardiol

    Association between planetary health diet and cardiovascular disease: a prospective study from the UK Biobank

    Cohort study

  40. Eur Heart J

    European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics

    Cross-sectional study

All 838 Briefs in ExploreShowing Briefs 561–600 of 838, newest first